Composition and release form
The drug is available from the pharmacy in the form of leniment for external use. It has a brown tint, a homogeneous, moderately thick consistency and an unexpressed characteristic odor of the medicine. Packaged in small 20 g tubes and secondary cardboard packaging. One pack contains 1 tube and instructions for taking the product are included.
The active substance is diethylbenzimidazolium triiodide. Auxiliary components: povidone, glycerin, petroleum jelly, dimexide.
The drug Stellanin is available from the pharmacy according to a doctor's prescription.
Ointment Stellanin and Levomekol - which is better
Manufacturer: OJSC NIZHFARM
Release form: ointment
Active ingredient: chloramphenicol, methyluracil
Levomekol is a combined analogue of the drug Stellanin, which has a regenerating and antimicrobial effect, promoting the healing of purulent wounds in the first phase of the wound process.
Used in otolaryngology, gynecology, urology and proctology.
Levomekol should be used with caution in children under 1 year of age, pregnant and lactating women. Before using the analogue, you must consult a doctor.
Levomekol, like Stellanin, has antimicrobial and anti-inflammatory effects. medicinal products are prescribed for skin damage after surgery. Levomekol is used for acne, calluses, and otitis media.
The ointment is widely used in pediatrics. Before starting use, consult a doctor.
Also, the analogue of Stellanin will please you with its comparatively lower cost.
pharmachologic effect
The pharmacological activity of the drug consists of antibacterial, antimicrobial, anti-inflammatory and regenerative effects.
Due to the iodine in the composition, the drug has a bactericidal effect, destroying pathogenic microbes on the surface of the dermis.
The pharmaceutical product prevents the development of infections in the wound and accelerates the regeneration process.
The therapeutic effect of the drug is manifested against streptococcus, staphylococcus, Proteus, candida and some other pathogenic agents.
Stellanin-peg 3% 20g ointment for external use
pharmachologic effect
Antiseptic.
Composition and release form Stellanin-peg 3% 20g ointment for external use
Composition per 100 g ointment:
- Active substance: 1,3-Diethylbenzimidazolium triiodide – 3.0 g;
- Excipients: Povidone K-17 (low molecular weight polyvinylpyrrolidone) – 2.0 g; Dimethyl sulfoxide (Dimexide) – 5.0 g; Macrogol 1500 (Polyethylene oxide 1500, Polyethylene glycol 1500) – 25.0 g; Macrogol 400 (Polyethylene oxide 400, Polyethylene glycol 400) – 65.0 g.
Ointment for external use 3%. 20 g in aluminum tubes along with instructions for use in cardboard packs.
Description of the dosage form
The ointment is dark brown in color with a weak characteristic odor.
Directions for use and doses
The ointment is applied in a thin layer of about 1.5-2 mm directly to the wound surface, after which a sterile gauze bandage is applied or the drug is applied to the dressing material and then to the wound. The ointment layer should exceed the circumference of the wound by at least 5 mm. Tampons soaked in ointment are loosely filled into the cavities of purulent wounds after surgical treatment, and gauze turundas with the drug are injected into the fistulous tracts. If the wound is localized in a place that is inconvenient for bandaging, it is permissible to use an adhesive bandage or adhesive bandage. The dressings are changed 1-2 times a day.
The daily dose should not exceed 10 g. The duration of treatment is on average 5-15 days.
For minor skin damage (abrasions, cuts, scratches, cracks, scratches), the drug is applied in a thin layer to the affected surface twice a day.
Pharmacodynamics
The mechanism of pharmacological activity of the drug is the antibacterial effect of 1,3-diethylbenzimidazolium. Active iodine, which is part of 1,3-diethylbenzimidazolium triiodide, inactivates bacterial wall proteins and bacterial enzyme proteins, thereby exerting a bactericidal effect on microorganisms. The pronounced antimicrobial effect of the drug prevents wound infection.
Along with antibacterial and anti-inflammatory effects, the ointment has a high osmotic potential, which is especially important in the treatment of purulent wounds, because promotes the evacuation of purulent discharge from the wound defect.
Pharmacokinetics
Systemic absorption of the active substance is absent even with damaged skin, however, therapeutic concentrations of the drug are present in the wound.
Indications for use Stellanin-peg 3% 20g ointment for external use
- Treatment of acute purulent processes (wounds) of the skin and soft tissues (boils, carbuncles, hydroadenitis, phlegmon, abscesses).
- Additional treatment of purulent complications of postoperative wounds (after excision, coagulation, episiotomy, for the treatment of skin cracks, wounds and sutures).
- Thermal lesions of the skin and soft tissues of I-III degrees, complicated by an infectious process.
- Trophic ulcers, bedsores, complicated by an infectious process.
- Abrasions, cuts, scratches, cracks, scratches.
Contraindications
Hypersensitivity to the components of the drug, thyrotoxicosis, thyroid adenoma, renal failure, simultaneous therapy with radioactive iodine, children under 18 years of age, first trimester of pregnancy.
Carefully
Chronic renal failure, II and III trimesters of pregnancy, lactation period.
special instructions
Avoid getting the ointment in your eyes. If the drug gets into your eyes, rinse with warm water.
Overdose
Cases of overdose have not been described. If you accidentally take the drug orally, nausea and vomiting may occur. It is necessary to rinse the stomach and consult a doctor; if necessary, carry out symptomatic treatment.
Side effects Stellanin-peg 3% 20g ointment for external use
In rare cases, allergic skin reactions (itching, skin hyperemia) are possible, and if they occur, you should stop using the drug.
Drug interactions
The drug should not be used in combination with other antiseptics containing mercury, oxidizing agents, alkalis and cationic surfactants. An alkaline or acidic environment, the presence of fat, pus, and blood weaken the antiseptic activity.
Indications
The main indications for use of the ointment are:
- Trophic extensive ulcers on the legs.
- Bedsores of varying severity.
- Burns of the dermis, in particular 1-2 degrees.
- Violation of the integrity of the skin - superficial and deep wound formations, cuts, various scratches, scratches and marks after insect bites.
- Prevention of infection of wound surfaces during surgery.
- Creating favorable conditions for better engraftment of the skin graft.
Contraindications
Absolute contraindications to the use of the drug Stellanin are:
- Pathological conditions of the thyroid gland (adenoma, increase in thyroid hormones).
- Parallel use of pharmaceutical drugs with radioactive iodine by the patient.
- Severe kidney disease.
- Age less than 18 years.
- The first 3 months of bearing a child.
- Individual intolerance to active and additional components.
With extreme caution and under the strict supervision of a specialist, the ointment is prescribed during breastfeeding, the 2nd and 3rd trimesters of pregnancy, and the last stage of kidney failure.
Instructions for Stellanin ointment
According to the instructions, the drug Stellanin is intended for external use. Leniment is applied to the surface of the skin with a thin layer of 1-2 mm.
The duration of treatment and dosage depend on the severity of the pathological process and the location of the damaged areas. The maximum daily dose of the drug is not more than 10 g. If necessary, you can apply a patch or occlusive dressing over the ointment.
For the treatment of wound surfaces, areas of skin with technical tongues and burns, the product is applied in an equal layer, no thicker than 1.5 mm, over the entire affected area. A sterile gauze bandage is applied on top. In case of such diseases, its replacement is carried out once every 1-2 days for skin burns and twice a day for wound injuries and trophic ulcers of the lower extremities. The duration of the course is individual, depending on the restoration of the skin.
For small cracks, scratches, scratches and abrasions, apply the ointment up to 2 times a day in a small and even layer to the affected area.
Instructions for medical use of the drug Stellanin®
Registration number: LSR-000269/09 dated January 19, 2009
Trade name: Stellanin®
Chemical name: 1,3-diethylbenzimidazolium triiodide
Dosage form: Ointment for external use
Composition in 100 g of ointment: Active substance: 1,3-diethylbenzimidazolium triiodide - 3.0 g Excipients: povidone (low molecular weight polyvinylpyrrolidone), dimexide, glycerol (glycerin), petroleum jelly
Description: Dark brown ointment with a weak characteristic odor
Pharmacotherapeutic group: Tissue regeneration stimulator
ATX code : D08AC
Pharmacological properties: Pharmacodynamics The active component of the drug Stellanin® is 1,3-diethylbenzimidazolium triiodide. The mechanism of pharmacological activity of the drug lies in the direct regenerative effect of 1,3-diethylbenzimidazolium on damaged skin. Active iodine, which is part of the drug, inactivates bacterial wall proteins and bacterial enzyme proteins, thereby exerting a bactericidal effect. Stellanin protects the surface of the wound from infections, suppresses the course of the infectious process and promotes healing.
Pharmacokinetics Systemic absorption of the active substance is absent even with damaged skin, however, therapeutic concentrations of the drug are present in the wound.
Indications for use:
- trophic ulcers of the lower extremities;
- bedsores;
- burns of I and II degrees;
- abrasions, cuts, scratches, cracks, scratches, including after insect bites;
- additional treatment of aseptic postoperative wounds (after excision, coagulation, episiotomy, for the treatment of skin cracks, wounds and sutures);
- acceleration of skin graft engraftment.
Contraindications: Hypersensitivity to the components of the drug, thyrotoxicosis, thyroid adenoma, renal failure, simultaneous therapy with radioactive iodine, children under 18 years of age, first trimester of pregnancy.
With caution: Chronic renal failure, II and III trimesters of pregnancy, lactation period.
Directions for use and dosage: Externally. The drug is applied to the damaged skin surface so that the skin area is completely covered with the drug. The duration and frequency of application of the drug depends on the severity of the disease and the location of the process. The daily dose should not exceed 10 g. It is possible to use occlusive dressings and patches. When treating granulating burns, wounds and trophic ulcers with weak exudation, the drug is applied in a uniform layer 1.0-1.5 mm thick so that the entire affected surface is covered with ointment, and a sterile gauze bandage is applied. Dressings are changed once every 1-2 days when treating burns and 1-2 times a day when treating wounds and trophic ulcers. With the open method of treating burns, the drug is applied 1-2 times a day. The duration of treatment is determined by the dynamics of wound epithelization. For minor skin damage (abrasions, cuts, scratches, cracks, scratches), the drug is applied in a thin layer to the affected surface 2 times a day.
Side effects: In rare cases, allergic skin reactions (itching, skin flushing) are possible, if they occur, you should stop using the drug.
Overdose: Cases of overdose have not been described. If the drug is accidentally taken orally, nausea and vomiting may occur. It is necessary to rinse the stomach and consult a doctor; if necessary, carry out symptomatic treatment.
Interaction with other drugs: The drug should not be used in combination with other antiseptics containing mercury, oxidizing agents, alkalis and cationic surfactants. In the presence of blood, the bactericidal effect of the drug may decrease.
Special instructions: The ointment should not be applied to mucous membranes. If the drug gets into the eyes or mucous membrane, rinse with warm water.
Release form: Ointment for external use 3%. 20 g in aluminum tubes along with instructions for use in cardboard packs.
Storage conditions: In a dry place, protected from light, at a temperature of 0-25 ° C. Keep out of the reach of children.
Shelf life: 2 years. Do not use after the expiration date stated on the packaging.
Conditions for dispensing from pharmacies: Without a prescription.
Manufacturer/Enterprise accepting quality claims: Pharmpreparat LLC 346780 Russian Federation, Rostov region, Azov, st. Kalinina, 2 Tel./fax: (86342) 5-26-39
